Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Pimavanserin (Nuplazid) Improve Sleep in Patients With Parkinson Disease Psychosis? A Pilot Study

NCT05796167 is registered in ClinicalTrials.gov with State University of New York - Downstate Medical Center as lead sponsor.

NCT NCT05796167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Pimavanserin (Nuplazid) Improve Sleep in Patients With Parkinson Disease Psychosis? A Pilot Study
Lead sponsor
State University of New York - Downstate Medical Center
Phase
Phase 1
Overall status
Withdrawn
Start date
January 27, 2023
Completion date
June 24, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease